Cyprina-T

Cyprina-T Syrup (Cyproheptadine 2mg + Tricholine Citrate 275mg) is a high-turnover, high-profit product built for our PCD Pharma Franchise partners.

This established combination is essential for improving appetite, promoting weight gain, and supporting liver function (Tricholine Citrate). This guarantees strong, persistent demand across both the pediatric and general physician segments.

Why Cyprina-T is Your Key to Profit:

High Volume, Consistent Demand: As a widely prescribed appetite stimulant and liver tonic, this product ensures rapid restocking cycles and consistently high sales volume throughout the year.

Excellent Profit Margins: Positioned in a high-demand therapeutic segment, the product allows for competitive pricing while securing superior profit margins on every unit sold.

Doctor Loyalty: The established, reliable composition builds immediate prescription trust from pediatricians and general practitioners, securing your long-term repeat orders.

Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated territory. Partner with us for full marketing support and timely supply to turn this essential, fast-moving product into guaranteed business growth.

Contact us today to secure this high-turnover syrup segment!

Patients may experience injection site discomfort, gastrointestinal upset (nausea, vomiting, diarrhea), rash, or mild liver enzyme elevations. Less commonly, hypersensitivity reactions and hematologic abnormalities such as eosinophilia or neutropenia may occur. Rare instances of C. difficile-associated diarrhea should be considered during prolonged use.

This formulation is used in the treatment of severe systemic infections such as urinary tract infections, lower respiratory tract infections (including pneumonia), intra-abdominal infections, skin and soft tissue infections, gynecological infections, and septicemia caused by susceptible gram-negative bacteria. It is particularly valuable in hospital-acquired infections or polymicrobial infections when used in combination with other antimicrobials.

This injection should only be used under the supervision of a qualified healthcare professional. Renal function should be monitored in long-term or high-dose treatments, and dose adjustment may be required in renal impairment. Aztreonam is not effective against gram-positive or anaerobic organisms, and should be used in combination therapy if mixed infections are suspected.

Store in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed and out of reach of children.